Claire Rychlewski is an Editor at Axios Pro. She focuses on the intersection of health and wellness with finance and investment, covering topics such as startups, venture capital, and private equity within the healthcare sector. Claire's insights and analyses have been featured in Axios.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Claire Rychlewski's coverage focuses on business, tech, health, healthcare & pharmaceutical industries. She appears to prioritize articles that include press releases and private sector announcements. Her article titles mostly revolve around mergers and acquisitions in the healthcare industry.
If you are looking to pitch to Claire Rychlewski, consider offering insights into recent M&A activities or significant developments within the healthcare, medtech, or telehealth sectors. Additionally, providing data-backed analysis or exclusive access to notable industry figures could be appealing to her given her frequent citations of data in her articles.
Given that there is no specified geographic focus for Claire’s coverage attributes suggest she takes a broad view of these industries with interest in international as well as domestic market movements and trends.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Available treatments for tremors caused by neurodegenerative diseases like Parkinson's carry risks including side effects and complications.
By: Claire Rychlewski, Erin Brodwin, Dan Primack
Walgreens shares spiked more than 20% on Tuesday, following a Wall Street Journal report that the company is in talks to be taken private by private equity firm Sycamore Partners.
There's room for a health-focused sponsor or a strategic in distribution to stake their claims in Walgreens' more profitable divisions.
Nordstrom will be taken private by members of its founding family and El Puerto de Liverpool, the company announced today
By: Erin Brodwin, Aaron Weitzman, Claire Rychlewski
The explosion of infusion therapies gives sponsors the chance to get a cut of the growing pharma market without taking on drug development.
Around 6% of Americans will develop PTSD at some point, but access to care remains very limited.
By: Aaron Weitzman, Claire Rychlewski
Soleo Health operates more than 40 U.S. infusion locations.
New Mountain beat out several big PE names for the business, underscoring how valuable RCM assets are.
By: Erin Brodwin, Aaron Weitzman, Claire Rychlewski
Despite antitrust scrutiny over UnitedHealth's dominance in the provider market, its Optum unit continues to acquire specialty providers.
By: Claire Rychlewski
The parties will likely still have to defend their proposed $3.3 billion merger in court.
(833) 317-6278 
